G1 Therapeutics Q4 EPS $(0.67) Beats $(0.87) Estimate, Sales $16.55M Beat $4.06M Estimate
G1 Therapeutics Q4 EPS $(0.67) Beats $(0.87) Estimate, Sales $16.55M Beat $4.06M Estimate
G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.87) by 22.99 percent. This is a 28.72 percent increase over losses of $(0.94) per share from the same period last year. The company reported quarterly sales of $16.55 million which beat the analyst consensus estimate of $4.06 million by 307.54 percent.
G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.87) by 22.99 percent. This is a 28.72 percent increase over losses of $(0.94) per share from the same period last year. The company reported quarterly sales of $16.55 million which beat the analyst consensus estimate of $4.06 million by 307.54 percent.
G1治療公司(納斯達克:GTHX)公佈季度虧損為每股0.67美元,比分析師普遍預期的(0.87美元)高出22.99%。這比去年同期每股虧損0.94美元增加了28.72%。該公司公佈季度銷售額為1,655萬美元,比分析師普遍預期的406萬美元高出307.54個百分點。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧